Company / CapEx per Share
Rapport Therapeutics, Inc. CapEx per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.12
FY2024
5-year range
$0.12 / $1.09
FY2023-FY2024
Trend
-89.3%
vs FY2023
Sector context
#53 of 192
Health Care
What the data says
At $0.12, Rapport Therapeutics, Inc.'s capex per share ranks #53 of 192 in the Health Care sector.
Based on SEC 10-K filings.
0.12 in FY2024.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 192 in Health CareTop 28% of 192This company $0.12 Sector average $3.54
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 89.3% year-over-year.
- Ranks #53 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.12 | -89.3% |
| FY2023 | $1.09 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026